Protagenic Therapeutics, Inc.\new Stock-Based Compensation
Protagenic Therapeutics, Inc.\new (PTIX) reported Stock-Based Compensation of $67.01 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-19
- Protagenic Therapeutics, Inc.\new share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $67.01K, a 46.44% decline year-over-year.
- Protagenic Therapeutics, Inc.\new share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $91.65K, a 61.17% decline year-over-year.
- Protagenic Therapeutics, Inc.\new share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $95.94K, a 60.91% decline year-over-year.
- Protagenic Therapeutics, Inc.\new share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $105.87K, a 57.72% decline year-over-year.
- Protagenic Therapeutics, Inc.\new share-based payment arrangement, noncash expense for fiscal 2026 was $418.59K.
- Protagenic Therapeutics, Inc.\new share-based payment arrangement, noncash expense for fiscal 2024 was $923.14K, a 38.44% increase from fiscal 2023.
- Protagenic Therapeutics, Inc.\new share-based payment arrangement, noncash expense for fiscal 2023 was $666.83K, a 22.88% decline from fiscal 2022.
- Protagenic Therapeutics, Inc.\new share-based payment arrangement, noncash expense for fiscal 2022 was $864.68K, a 43.07% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $67.01K 10-Q · filed 2026-08-19 | $158.66K derived: sum of 2 quarters · filed 2026-08-19 | $254.61K derived: sum of 3 quarters · filed 2026-08-19 | $360.47K derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $91.65K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-14 | $187.59K derived: sum of 2 quarters · filed 2026-08-14 | $293.46K derived: sum of 3 quarters · filed 2026-08-14 | $418.59K 10-K · filed 2026-08-14 |
| 2025-12-31 | $95.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-09 | $201.81K derived: sum of 2 quarters · filed 2026-03-09 | $326.94K 10-Q · filed 2026-03-09 | $562.95K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-09-30 | $105.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-26 | $231.00K 10-Q · filed 2025-11-26 | $467.01K derived: sum of 3 quarters · filed 2026-08-19 | $712.45K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $125.13K 10-Q · filed 2026-08-19 | $361.14K derived: sum of 2 quarters · filed 2026-08-19 | $606.58K derived: sum of 3 quarters · filed 2026-08-19 | $856.98K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $236.01K 10-Q · filed 2025-05-13 | $481.45K derived: sum of 2 quarters · filed 2025-05-13 | $731.85K derived: sum of 3 quarters · filed 2025-05-13 | $997.29K derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | $245.44K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $495.84K derived: sum of 2 quarters · filed 2025-03-31 | $761.28K derived: sum of 3 quarters · filed 2025-03-31 | $923.14K 10-K · filed 2025-03-31 |
| 2024-09-30 | $250.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $515.84K derived: sum of 2 quarters · filed 2024-11-14 | $677.70K 10-Q · filed 2024-11-14 | $844.41K derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-06-30 | $265.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $427.30K 10-Q · filed 2024-08-14 | $594.01K derived: sum of 3 quarters · filed 2025-05-13 | $760.71K derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-03-31 | $161.86K 10-Q · filed 2025-05-13 | $328.57K derived: sum of 2 quarters · filed 2025-05-13 | $495.27K derived: sum of 3 quarters · filed 2025-05-13 | $661.98K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $166.71K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $333.41K derived: sum of 2 quarters · filed 2025-03-31 | $500.12K derived: sum of 3 quarters · filed 2025-03-31 | $666.83K 10-K · filed 2025-03-31 |
| 2023-09-30 | $166.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $333.41K derived: sum of 2 quarters · filed 2024-11-14 | $500.12K 10-Q · filed 2024-11-14 | $698.81K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $166.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $333.41K 10-Q · filed 2024-08-14 | $532.10K derived: sum of 3 quarters · filed 2024-08-14 | $746.78K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $166.71K 10-Q · filed 2024-05-15 | $365.39K derived: sum of 2 quarters · filed 2024-05-15 | $580.07K derived: sum of 3 quarters · filed 2024-05-15 | $795.61K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $198.69K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-05-14 | $413.37K derived: sum of 2 quarters · filed 2024-05-14 | $628.90K derived: sum of 3 quarters · filed 2024-05-14 | $864.68K 10-K/A · filed 2024-05-14 |
| 2022-09-30 | $214.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $430.21K derived: sum of 2 quarters · filed 2023-11-14 | $665.99K 10-Q · filed 2023-11-14 | $884.16K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $215.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $451.31K 10-Q · filed 2023-08-14 | $669.48K derived: sum of 3 quarters · filed 2023-08-14 | $901.13K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $235.78K 10-Q · filed 2023-05-15 | $453.94K derived: sum of 2 quarters · filed 2023-05-15 | $685.59K derived: sum of 3 quarters · filed 2023-05-15 | $1.41M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $218.17K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $449.81K derived: sum of 2 quarters · filed 2023-03-31 | $1.17M derived: sum of 3 quarters · filed 2023-03-31 | $1.52M 10-K · filed 2023-03-31 |
| 2021-09-30 | $231.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $954.62K derived: sum of 2 quarters · filed 2022-11-14 | $1.30M 10-Q · filed 2022-11-14 | $1.71M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $722.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.07M 10-Q · filed 2022-08-11 | $1.48M derived: sum of 3 quarters · filed 2022-08-11 | $1.97M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $345.98K 10-Q · filed 2022-05-13 | $757.58K derived: sum of 2 quarters · filed 2022-05-13 | $1.25M derived: sum of 3 quarters · filed 2022-05-13 | $1.64M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $411.60K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-07 | $903.20K derived: sum of 2 quarters · filed 2022-04-07 | $1.29M derived: sum of 3 quarters · filed 2022-04-07 | $1.65M 10-K · filed 2022-04-07 |
| 2020-09-30 | $491.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $882.72K derived: sum of 2 quarters · filed 2021-11-15 | $1.24M 10-Q · filed 2021-11-15 | $1.19M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $391.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $751.55K 10-Q · filed 2021-08-16 | $698.55K derived: sum of 3 quarters · filed 2021-08-16 | $837.61K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $360.44K 10-Q · filed 2021-05-17 | $307.43K derived: sum of 2 quarters · filed 2021-05-17 | $446.50K derived: sum of 3 quarters · filed 2021-05-17 | $707.06K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | -$53.01K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $86.06K derived: sum of 2 quarters · filed 2021-03-25 | $346.62K derived: sum of 3 quarters · filed 2021-03-25 | $797.76K 10-K · filed 2021-03-25 |
| 2019-09-30 | $139.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $399.63K derived: sum of 2 quarters · filed 2020-11-16 | $850.77K 10-Q · filed 2020-11-16 | $1.11M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $260.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $711.70K 10-Q · filed 2020-08-14 | $972.84K derived: sum of 3 quarters · filed 2020-08-14 | $1.23M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $451.14K 10-Q · filed 2020-06-18 | $712.28K derived: sum of 2 quarters · filed 2020-06-18 | $973.42K derived: sum of 3 quarters · filed 2020-06-18 | $1.24M derived: sum of 4 quarters · filed 2020-06-18 |
| 2018-12-31 | $261.14K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29 | $522.28K derived: sum of 2 quarters · filed 2020-04-29 | $785.42K derived: sum of 3 quarters · filed 2020-04-29 | $1.13M 10-K · filed 2020-04-29 |
| 2018-09-30 | $261.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $524.29K derived: sum of 2 quarters · filed 2019-11-14 | $868.93K 10-Q · filed 2019-11-14 | $1.10M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $263.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $607.79K 10-Q · filed 2019-08-14 | $841.37K derived: sum of 3 quarters · filed 2019-08-14 | $995.20K derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $344.65K 10-Q · filed 2019-05-16 | $578.22K derived: sum of 2 quarters · filed 2019-05-16 | $732.05K derived: sum of 3 quarters · filed 2019-05-16 | $877.59K derived: sum of 4 quarters · filed 2019-05-16 |
| 2017-12-31 | $233.57K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $387.40K derived: sum of 2 quarters · filed 2019-03-29 | $532.95K derived: sum of 3 quarters · filed 2019-03-29 | $888.28K 10-K · filed 2019-03-29 |
| 2017-09-30 | $153.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $299.37K derived: sum of 2 quarters · filed 2018-11-08 | $654.71K 10-Q · filed 2018-11-08 | $750.27K derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | $145.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $500.88K 10-Q · filed 2018-08-14 | $596.45K derived: sum of 3 quarters · filed 2018-08-14 | $807.15K derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $355.34K 10-Q · filed 2018-05-15 | $450.90K derived: sum of 2 quarters · filed 2018-05-15 | $661.61K derived: sum of 3 quarters · filed 2018-05-15 | $798.56K derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $95.57K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $306.27K derived: sum of 2 quarters · filed 2018-04-02 | $443.23K derived: sum of 3 quarters · filed 2018-04-02 | $546.13K 10-K · filed 2018-04-02 |
| 2016-09-30 | $210.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $347.66K derived: sum of 2 quarters · filed 2017-11-13 | $450.57K 10-Q · filed 2017-11-13 | $570.22K derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | $136.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $239.87K 10-Q · filed 2017-08-08 | $359.52K derived: sum of 3 quarters · filed 2017-08-08 | $637.42K derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $102.91K 10-Q · filed 2017-05-15 | $222.56K derived: sum of 2 quarters · filed 2017-05-15 | $500.46K derived: sum of 3 quarters · filed 2017-05-15 | $556.74K derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $119.66K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-05-08 | $397.55K derived: sum of 2 quarters · filed 2017-05-08 | $453.83K derived: sum of 3 quarters · filed 2017-05-08 | $478.63K 10-K/A · filed 2017-05-08 |
| 2015-09-30 | $277.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-17 | $334.17K derived: sum of 2 quarters · filed 2016-11-17 | $358.97K 10-Q · filed 2016-11-17 | |
| 2015-06-30 | $56.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $81.08K 10-Q · filed 2016-08-15 | $0.00 10-K · filed 2015-09-25 | |
| 2015-03-31 | $24.80K 10-Q · filed 2016-07-25 | $0.00 10-Q · filed 2015-05-11 | ||
| 2014-12-31 | $85.17K 8-K/A · filed 2016-07-12 | |||
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-25 | $275.00K 10-K · filed 2015-09-25 | ||
| 2014-03-31 | $275.00K 10-Q · filed 2015-05-11 | |||
| 2011-09-30 | $33.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $285.00K 10-Q · filed 2011-11-14 | ||
| 2011-06-30 | $252.00K 10-Q/A · filed 2011-09-07 | |||
| 2010-09-30 | $225.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $860.00K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $635.00K 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |